Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19
Sponsor: Henry Ford Health System
Summary
This study is a comparison of the ID Now COVID-19 (Abbott) assay to the Accula SARS-CoV-2 (Mesa Biotech) assay to assist in the identification of infection with COVID-19. The tests will be compared for sensitivity, specificity, positive predictive value and negative predictive value.
Official title: Comparison of the ID NOW and Accula Point-of-Care Assays for the Detection of Severe Acute Respiratory System CoV-2 (SARS-CoV-2)
Key Details
Gender
All
Age Range
18 Years - 95 Years
Study Type
OBSERVATIONAL
Enrollment
0
Start Date
2020-05-10
Completion Date
2021-05-09
Last Updated
2026-08-10
Healthy Volunteers
Not specified
Conditions
Interventions
ID NOW vs. Accula
Comparison of the ID Now assay vs. the Accula assay in detecting Covid-19.
Locations (1)
Ascension St. John Hospital
Detroit, Michigan, United States